A Novel Huntington’s Disease Assessment Platform to Support Future Drug Discovery and Development

Huntington’s disease (HD) is a lethal neurodegenerative disorder without efficient therapeutic options. The inefficient translation from preclinical and clinical research into clinical use is mainly attributed to the lack of (i) understanding of disease initiation, progression, and involved molecula...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jingyun, Möhle, Luisa, Brüning, Thomas, Eiriz, Iván, Rafehi, Muhammad, Stefan, Katja, Stefan, Sven Marcel, Pahnke, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740291/
https://www.ncbi.nlm.nih.gov/pubmed/36499090
http://dx.doi.org/10.3390/ijms232314763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740291/
https://www.ncbi.nlm.nih.gov/pubmed/36499090
http://dx.doi.org/10.3390/ijms232314763

Ejemplares similares